Picture of Nykode Therapeutics ASA logo

NYKD — Nykode Therapeutics ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Nykode Therapeutics: Issuance Of Key Patent Covering Individualized Neoantigen Based Vaccines

Aug 14 (Reuters) - Nykode Therapeutics ASA  NYKD.OL :
    * NYKODE THERAPEUTICS ANNOUNCES ISSUANCE OF KEY PATENT
COVERING
INDIVIDUALIZED NEOANTIGEN BASED VACCINES
    * 20 YEAR EXPIRATION DATE OF THIS PATENT IS JANUARY 5, 2037
    * UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) HAS
ISSUED
U.S. PATENT NO. 12,059,459

Source text for Eikon:  ID:nObiTRZz6a 
Further company coverage:  NYKD.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Nykode Therapeutics ASA

See all news